» Articles » PMID: 35139904

Therapeutic Effect of Adipose Stromal Vascular Fraction Spheroids for Partial Bladder Outlet Obstruction Induced Underactive Bladder

Overview
Publisher Biomed Central
Date 2022 Feb 10
PMID 35139904
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Underactive bladder (UAB) is a common clinical problem but related research is rarely explored. As there are currently no effective therapies, the administration of adipose stromal vascular fraction (ad-SVF) provides a new potential method to treat underactive bladder.

Methods: Male Sprague-Dawley rats were induced by partial bladder outlet obstruction (PBOO) for four weeks and randomly divided into three groups: rats treated with PBS (Sham group); rats administrated with ad-SVF (ad-SVF group) and rats performed with ad-SVF spheroids (ad-SVFsp group). After four weeks, urodynamic studies were performed to evaluate bladder functions and all rats were sacrificed for further studies.

Results: We observed that the bladder functions and symptoms of UAB were significantly improved in the ad-SVFsp group than that in the Sham group and ad-SVF group. Meanwhile, our data showed that ad-SVF spheroids could remarkably promote angiogenesis, suppress cell apoptosis and stimulate cell proliferation in bladder tissue than that in the other two groups. Moreover, ad-SVF spheroids increased the expression levels of bFGF, HGF and VEGF-A than ad-SVF. IVIS Spectrum small-animal in vivo imaging system revealed that ad-SVF spheroids could increase the retention rate of transplanted cells in bladder tissue.

Conclusions: Ad-SVF spheroids improved functions and symptoms of bladder induced by PBOO, which contributes to promote angiogenesis, suppress cell apoptosis and stimulate cell proliferation. Ad-SVF spheroids provide a potential treatment for the future patients with UAB.

Citing Articles

Lesson on obesity and anatomy of adipose tissue: new models of study in the era of clinical and translational research.

Luca T, Pezzino S, Puleo S, Castorina S J Transl Med. 2024; 22(1):764.

PMID: 39143643 PMC: 11323604. DOI: 10.1186/s12967-024-05547-3.


Efficacy of autologous micrografts technology: a promising approach for chronic wound healing and tissue regeneration-a pilot study.

Baglioni E, Perego F, Paolin E, Abate A, Pusceddu T, Zavan B Front Med (Lausanne). 2024; 11:1417920.

PMID: 39131083 PMC: 11310043. DOI: 10.3389/fmed.2024.1417920.

References
1.
Gani J, Hennessey D . The underactive bladder: diagnosis and surgical treatment options. Transl Androl Urol. 2017; 6(Suppl 2):S186-S195. PMC: 5522796. DOI: 10.21037/tau.2017.04.07. View

2.
Chen Z, Xie J, Hao H, Lin H, Wang L, Zhang Y . Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3β/cyclin D1 signalling pathway. Cardiovasc Res. 2017; 113(6):620-632. PMC: 5412017. DOI: 10.1093/cvr/cvx001. View

3.
Kim J, Park Y, Jung Y, Kim S, Kim S . Combinatorial therapy with three-dimensionally cultured adipose-derived stromal cells and self-assembling peptides to enhance angiogenesis and preserve cardiac function in infarcted hearts. J Tissue Eng Regen Med. 2016; 11(10):2816-2827. DOI: 10.1002/term.2181. View

4.
Zhao F, Zhou L, Liu J, Xu Z, Ping W, Li H . Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering. J Tissue Eng. 2019; 10:2041731419891256. PMC: 6886281. DOI: 10.1177/2041731419891256. View

5.
Huang J, Maier C, Zhang Y, Soare A, Dees C, Beyer C . Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis. Ann Rheum Dis. 2017; 76(11):1941-1948. DOI: 10.1136/annrheumdis-2016-210823. View